# Course 2 : Module 6: Clinical Data : Electronic Phenotyping

**Sources:** 12 | **Exported:** July 14, 2026

---

## 1. Approaches for creating a probabilistic phenotype definition.mp4

### Summary

Modern medical research utilizes **probabilistic phenotyping** to identify patient conditions by leveraging large-scale, imperfect data rather than relying solely on scarce, expert-verified labels. This approach operates on the principle that **expanding the sample size** can mathematically compensate for inaccuracies, allowing researchers to build robust models from noisy information like billing code frequencies or keyword searches. By employing techniques such as **anchors**—highly reliable indicators used as proxies for a diagnosis—scientists can efficiently generate massive training sets with minimal human intervention. Ultimately, this methodology represents a **trade-off between effort and precision**, demonstrating that a vast quantity of slightly flawed data often produces more effective diagnostic classifiers than a small pool of perfect data.

**Keywords:** Probabilistic phenotype definition, Patient data clustering, Imperfect labeling accuracy, Knowledge graph expansion, Anchor-based classifiers

### Content

There are a couple of approaches to go by this probabistic phenotype definition. One probabilistic phenotyping procedure computes the number of times billing codes are applied to each patient and interprets that count as a probability of having the phenotype. This is based on the intuition that small counts might be sputious but high counts are not likely to be spurious. Then using that estimated probability, we can cluster the patients into those that are likely to have the disease and those that are not likely to have the disease. That research illustrates an important point. In general, it's easier to acquire more imperfectly labeled data than it is to increase the accuracy of the labels. Turns out that the error rate in labeling can also be reduced by increasing the sample size. There's even a mathematical formula for this. The expansion of the sample size is equal to 1 / 1 - 2 t² where t is the error rate. Suppose that 500 accurate labeled cases would be enough data for learning a good classifier. Increasing this set to 1,500 cases would be an expansion factor of three, which would allow the use of imperfectly labeled data with an error rate of about 21%. Most large observational data sets should be large enough for this purpose. Here's another approach using imperfect data. Start with keywords for the condition of interest such as parallel infuction. Expand the set of keywords to include related terms using a knowledge graph. Include all patients who have those keywords as non-negated mentions somewhere on their timeline. Then train a classifier using all those features to classify the phenotype. In this project, the classifiers performed well for diabetes malitis, myocardial inffection and familial hyper cholesterolmia, but less well for celiac disease. Another imperfect labeling system uses a notion called anchors. An anchor is a reliable indicator of the presence of a phenotype. That is, if you see the anchor, the patient is very likely to have the phenotype. But the converse is not necessarily true. The anchor is used as a labeling function to obtain large amounts of training data for a classifier. We can also track how much does our classifier get better with adding more anchors. As an example, for the phenotype, type of myio infarction. The performance increases for the first five anchors and then mostly plateaus. From a practical perspective, I encourage you to view this as a effort precision trade-off where a small amount of human effort gets you lots of training data and most of the performance improvement of your phenotype classifier.

---

## 2. Challenges in electronic phenotyping.mp4

### Summary

Accurate medical phenotyping requires a sophisticated approach because simple diagnostic codes are often **prone to inaccuracies** or chronological errors within a patient's history. While a code might suggest a condition, it is frequently just a **proxy for clinical reality** that fails to capture the exact moment a disease began or whether it was merely a suspected diagnosis. To solve this, researchers must differentiate between a **feature**, which is a raw, direct measurement like blood pressure, and a **phenotype**, which is a high-level **inference derived from multiple data points**. Ultimately, the goal is to transform a complex **timeline of patient features** into a meaningful medical conclusion through careful interpretation and data selection.

**Keywords:** Electronic phenotyping, ICD code accuracy, Patient feature timelines, Feature vs phenotype, Clinical data interpretation

### Content

Phenotyping might seem straightforward. Why not just use the disease codes such as the ICD 9 or ICD 10 that have been assigned to each patient? The first problem is that these codes might not be accurate. For example, the disease code might have been assigned while the doctor was doing tests to figure out if the patient has the disease. Even if the tests show that the disease is absent, the codes may still remain on the chart. The second problem is that even if the codes are correct, They might be assigned after the patient was first known to have the condition. For example, codes might be assigned upon discharge from the hospital even though the patient developed the condition during the hospitalization well before the day of discharge. In some analyses, this difference in time might matter. The input to electronic phenotyping procedure will be a timeline of the patient features. To figure out if the event of interest did happen and if so, when it happened, We need to choose which data to use and which portion of the timeline to consider. We need to distinguish a feature from a phenotype. A feature is something that is directly measured. A phenotype is the result of inference or some interpretation applied to one or more features. This distinction may seem subtle. So let's look at an example. Blood pressure is a feature. Hypertension is a phenotype. It's a judgment call based on blood pressure measurements. along with considerations of other features such as the persistence of the pressure elevation over time, the prescription of certain classes of medications, and the ordering of certain lab tests and their results.

---

## 3. Constructing a rule based phenotype definition.mp4

### Summary

To define a medical phenotype using a rule-based approach, experts engage in a rigorous, **iterative consensus process** that transforms clinical concepts into actionable data. The workflow begins by identifying essential clinical indicators and mapping them to **standardized medical codes** within a knowledge graph to ensure technical precision. Experts then construct logical frameworks that account for the **frequency, duration, and specific combination** of these codes required to confirm a diagnosis. Finally, the definition is refined through repeated **comparison against clinical gold standards** until the criteria consistently and accurately identify the target condition within patient records.

**Keywords:** Rule-based phenotype definitions, Patient data elements, Medical knowledge graphs, Code-based criteria, Iterative clinical validation

### Content

So, we just saw some examples of rule-based phenotype definitions. Well, how do we actually construct such a phenotype definition? Here's a summary of the steps which are followed by medical experts trying to arrive at a consensus. First, identify the data elements that should appear in a patient's record to infer that the patient has the condition of interest. Second, use a relevant knowledge graph to convert those data elements into specific identifiers such as the ICD9 code, ICD10 code, or medication codes. Third, create the definition by specifying the criteria based on the presence, absence of those codes, the necessary and sufficient conditions, the frequency of their occurrence, and the start and end conditions for those identifiers in the patient's record. Next, we iterate by comparison to some reference standard, usually a clinician review of the full chart. In each iteration, we ask, does our definition provide necessary for sufficient conditions for identifying the phenotype. Does the description identify when the condition starts and when it ends? What kind of data elements do we need for the definition? Using what you just learned, try to refine your definition. Repeat till everyone agrees.

---

## 4. Examples of rule based electronic phenotype definitions.mp4

### Summary

This source illustrates how medical professionals use complex **rule-based algorithms** to accurately identify specific patient conditions within electronic health records. By examining a case study of type 2 diabetes, the text demonstrates that relying solely on **billing codes is insufficient** for a precise diagnosis. Instead, a robust definition of a phenotype must integrate **multiple data streams**, such as medication history and laboratory results, while carefully considering the **chronological sequence of clinical events**. Ultimately, the passage emphasizes that combining these diverse information sources leads to **higher diagnostic accuracy** tailored to the unique characteristics of each disease.

**Keywords:** Electronic phenotype definitions, Type 2 diabetes, Algorithm flowchart, Patient record data, Electronic Medical Records

### Content

Let's turn to a more complex phenotype. This one is for type 2 diabetes motives. This one is also listed on fkb.org. This phenotype is expressed as a flowchart which is often called an algorithm. We'll describe parts of it and you can explore the rest by yourself. We start with the records of a patient stored in the EMR. If the patient has a diagnosis of type 1 diabetes militus, then we determine that the patient does not have type 2 diabetes. If there's no such diagnosis code for type 1 diabetes then we check for diagnosis of type 2 diabetes malitis. If there's no such diagnosis but if there are prescriptions for type 2 diabetes malitus drugs and relevant abnormal lab values then the patient is still assessed as having type 2 diabetes malitis or a case in this condition. There are other paths throughout that flowchart which you can explore on your own. The point here is that diagnosis codes are not accurate enough on their own but need to be augment mented by prescriptions of medications, specific lab values, and the consideration of the relative timing of events. Once again stressing the need to have codified prior knowledge and the need for adopting a timeline view of the patient record. The way 2015 paper which we mentioned in this course shows that the relative value of using billing codes, features from clinical text and medical records in constructing phenotype definitions for several important medical conditions. It's important to remember that each of these sources of data can be useful, that combinations of the sources are more accurate, and the relative value of a source varies with the disease of interest or the phenotype of interest.

---

## 5. Intro to Clinical Data Study Guide - M6.pdf

### Summary

This guide introduces **electronic phenotyping**, a computational methodology used to identify specific patient conditions or diseases by analyzing **electronic medical records**. The text distinguishes between **features**, which are direct clinical measurements, and **phenotypes**, which are complex clinical states inferred from those measurements across a patient’s timeline. To achieve this, researchers employ either **rule-based phenotyping**, which relies on expert-driven inclusion and exclusion criteria, or **probabilistic phenotyping**, which leverages **machine learning** and "anchors" to automate the classification process. Ultimately, these techniques serve to transform raw observational data into actionable insights for **clinical research**, trial recruitment, and healthcare quality assessment.

**Keywords:** Electronic phenotyping, Rule-based phenotyping, Probabilistic phenotyping, Clinical research data, Machine learning classifiers

### Content

[Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX-l8kIMwdS7aghhMrRs8XAzZp96wdVb9q5veK9AAcZ_wIVFrJr7DBeYYAZHz-PSbXzsYmNf7RMv3IuduMFjJ5hjvDGVi6VuKoEKJj_J2IhNI-c6ielKatpVT4oLN6azhjbvCXeW=w442-h129-v0)

[Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX_6nvwKoD0OrctsIuDjXulQE9EtOzTrkCfBURFHWdDLex3ZNJK6mhFEWpM58A6FdAybBXGxJIEJlKvA-J29Nn_JeBLttVc4wvTcUvx9cQh1QUknA8Eoe-m5b1IllfYwdwH4Oz-BOQ=w600-h73-v0)

 INTRO TO CLINICAL DATA STUDY GUIDE MODULE 6 - PUTTING THE PIECES TOGETHER: ELECTRONIC PHENOTYPING LEARNING OBJECTIVES 1. Define electronic phenotyping 2. Describe the difference between a feature and a phenotype 3. Explain the purpose of electronic phenotyping 4. Describe the two main approaches to electronic phenotyping, and their strengths and weaknesses 5. Describe imperfect labelling and how it can be used in phenotyping ELECTRONIC PHENOTYPING Phenotype is a certain characteristic or condition of a patient that may be present or absent. The most common example is a disease. Electronic phenotyping is a computational procedure for determining whether a patient does have or does not have the condition of interest based on electronic medical record. The process of electronic phenotyping is found throughout clinical research. Electronic phenotyping is useful for: Using observational data for research Recruiting into clinical trials Calculating quality metrics for healthcare systems Finding similar patients Sharing definitions to facilitate cross-site research Difficulties of Phenotyping: 1. The codes might not be accurate 2. Even if the codes are correct, they might be assigned after the patient was first known to have the condition [Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX_IDjoEuaH7IU2nCT8L9fX3oPWXVVfp4fKy6yxiNgKF4hBh2LxptxnSHnqO1FTfeswNQ-K74PGkny60Jcj8BAasylJ-YQcwHnyWfEFCEpboznXhNFgKHHcisrVdphxcPuRNPEEmaQ=w442-h129-v0)

[Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX8Z2b3XqEH5P20u1IZnGlG1cTth_zkmXwt-4fa4N3ue3Wxnilr0msEbU6ggPziZejHXX4bHsuvX0Hv9mHequKJ5f0hr-AAHkrdyWkdul5AoW5y3TasottolSgyOQxs14TSh75ARmA=w600-h73-v0)

 The input to electronic phenotyping procedure will be a timeline of the patient's features. We need to choose which data to use, and which portion of the timeline to consider. We need to distinguish a feature from a phenotype. A feature is something that is directly measured A phenotype is the result of inference applied to one or more features An electronic phenotype should contain the necessary and sufficient conditions of the features that should be present or absent and their required values to determine if an exposure or outcome of interest happened to a patient. It should also contain the criteria for identifying the start and end times. Locating the start time may be straightforward, it can be more difficult to determine when a condition ends. When specifying a phenotype, it is very important to be clear about the intended meaning of that phenotype. Evaluating a Phenotype Definition: Figure out exposures and outcomes Decide on risk thresholds Estimate the effects of treatments Electronic phenotyping: Declaring the necessary and sufficient conditions of the features that should be present or absent and their required values to determine if an exposure or outcome of interest happened It is important to realize that the accuracy of the phenotype definition depends on the research question you are trying to answer. The last issue to consider for evaluation is how well a phenotype definition based on data from one clinical site will work at a second clinical site, often referred to as the portability of the electronic phenotype. TWO APPROACHES TO PHENOTYPING Approaches to Electronic Phenotyping: 1. Rule-based Phenotyping: Using rules comprised of explicit inclusion and exclusion criteria that were constructed by experts who reach consensus on the criteria in an iterative fashion [Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX9DC0OcUY9fDPEX3k-Yucc0CJlb0mvP8AHaYfENJdgAoaNoRcRfr3iNCWJIFRcB7lkbc4UZTQVaL-bYMzqbBamNO12zCJZSTmKGnxequ9M5zczC-c1R6UXcWTJZ7YRKuoedffDn=w442-h129-v0)

[Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX-IP5pAR3xltIbWS9HujQW4w4IJCktE1o441fYWkvmPpPCZDD2sJHauLFKdrwUkr51hZrPYfhU9A29qChujs3KvrE4U9zMLRKbUnW3X5mz6ukCL7SvqvlgI1FzRWpntr1rgdQYb=w600-h73-v0)

[Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX8LyE_URsqB6F9-CrSHqkTlD0pWAjkTyoxZ367jY0QbzaC_xYOEjyDH_RAFo7buGPPwRgpCQV9_bGH-klJbnrYFU7mK8fJwPpuHZwK9oNYzUWDgHQDjygkLFmSHhywP-9GkvWCcXg=w1280-h621-v0)

 2. Probabilistic Phenotyping: Using machine learning instead of expert consensus to learn a function that assigns a probability to a patient’s record for having the exposure or outcome of interest RULE-BASED ELECTRONIC PHENOTYPING We will use examples from the Phenotype Knowledge Base, or PheKB. This is a publicly available repository of phenotype definitions. [Site: What is the Phenotype KnowledgeBase? | PheKB] The phenotype has inclusion criteria and exclusion criteria. The inclusion criteria are features that must be present, while the exclusion criteria are features that must not be present. Example of sickle cell disease: The inclusion criteria has two parts: a set of ICD-9 codes and the requirement for one hospitalization or two clinic visits for this condition. The exclusion criteria has one part, which says that if the patient has more diagnoses for sickle cell trait than for sickle cell disease, then do not determine the patient to have sickle cell disease. Example of type 2 diabetes mellitus: This phenotype is expressed as a flowchart, which they call an "algorithm". Starting with the records for a patient stored in the EMR; following “Yes” and “No” on whether the patient has diagnosed of Type 1 diabetes and check Type 2 diabetes diagnosis, prescription, or relevant abnormal lab value. The point here is that diagnosis codes are not accurate enough to be used on their own, but need to be augmented by prescriptions of medications, specific [Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX9m7hvAf00bl8Yb21PCWAkxR-wIQDXW_rKdpz7t_1HxHrGtp8bug8eNmmapFONMa__7hXOE4bGd0GlfTHtxslkYtcz-y75bLEgS2NSV-v-6NyPsmXeEB62YiaxIjAjZdgQ5zTrSbw=w442-h129-v0)

[Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX8bNTtYiryO4dqSpdAW7oGNLFGs2lh0KbPPS4yrdbyHABaUWy5pNbOg5vTWm8IXYsBwWKChTpJgACIs37brF-ULqL79b51_kmqIVWjqihnmMyYflBJ9AxLPgTH9txCXZAMMEY1d=w600-h73-v0)

[Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX8BFiMpo-Gj9BdDfnG1_lessrjOojx1GXAEzCqs9YbFDU9u_IqUI1-O_XGgTTSGcx0aac2dyyPIxuyc5Ag8z1FbGmlc8NdK4O3LhZHwHIqyfa926bEJ4kB9eHXpOGeO3V7RNdUatw=w1280-h570-v0)

 lab values, and consideration of the relative timing of events, stressing the need to have codified “prior knowledge” and adopting a timeline view of the patient record. It is important to remember that each of the sources of data can be useful, that combinations of the sources are more accurate, and that the relative value of a source varies with the disease of interest. Constructing a rule-based phenotype definition: 1. Identify the data elements that should appear in a medical record 2. Use a relevant knowledge graph to convert those data elements into specific identifiers 3. Create the phenotype definition by specifying the criteria 4. Iterate by comparison to some reference standard, usually clinician review of the full chart PROBABILISTIC PHENOTYPING Problem: Suppose you are the Chief Data Scientist at a healthcare startup. You need to identify patients who have one of fifty different conditions. The work needs to be completed within one week. What could you do? Solution: Use Supervised Machine Learning with a training dataset, with each patient explicitly labeled as having or not having the condition of interest. The training dataset is used to build a computational model that can classify whether a previously unseen patient has the condition. Approaches for Probabilistic phenotyping definition: Computes the number of times billing codes applied to each patient, and interprets that count as a probability of having the phenotype. Then using that estimated probability, cluster the patients into those likely to have the disease and those not likely. [Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX8Zgj4pP0W34elLWDGk3RF1_90px-Hnmcfoj5miC1xkcv6idNTf5Vnyx2o4qHTY5ps02KFLKHPFUfDHyRQYB6zABhHHeWcyvxdjPglhqvx2kx6aJqiJZnPq0knHRbkmRiaAnOOriA=w442-h129-v0)

[Image](https://lh3.googleusercontent.com/notebooklm/AKYWMX9rbFt66UctClbLpmV2nIzon9tMVu9itOpYCyO5ZuOVMY_ki1oRMwfOp_0C-DUZyLMSsCUlZzgbqH_jnK38HFoIElm1GTKadyWZxI03TAOVthc_Ju3eUmj1tPM14o1rZD73TBrhaQ=w600-h73-v0)

 A mathematical formula: The expansion of the sample size = 1/(1 - 2t)^2, where t = error rate Using imperfect data: 1. Start with keywords for the condition of interest 2. Expand the set of keywords to include related terms using a knowledge graph 3. Include all patients who have those keywords as non-negated mentions somewhere on their timeline 4. Then train a classifier using all the other features to classify the phenotype Another imperfect labeling system uses a concept called "anchors". An anchor is a reliable indicator of the presence of the phenotype. The anchor is used as a labeling function to obtain large amounts of training data for a classifier. We can also track how much does our classifier get better with adding more anchors. Software for Probabilistic Phenotype Definition: Aphrodite (Automated PHenotype Routine for Observational Definition, Identification, Training and Evaluation). It uses standardized, open-source representations: OHDSI CDMv5 and Vocabulary 5, and it implements the labeling. The code is freely available on github: http://github.com/OHDSI/Aphrodite

---

## 6. Introduction to electronic phenotyping.mp4

### Summary

Electronic phenotyping is a **computational method** used to determine if a patient possesses a specific medical condition by analyzing data within an **electronic medical record**. Beyond identifying the presence of a disease, this process establishes a **clinical timeline** to pinpoint exactly when a condition began and concluded. By synthesizing diverse data points like text and images, researchers can use these digital profiles to **recruit trial participants**, track healthcare quality, and find similar patient cohorts. Ultimately, this approach creates a **standardized language** for defining illnesses, which allows different medical institutions to collaborate and share research findings more effectively.

**Keywords:** Electronic phenotyping, Clinical research, Patient characteristics, Electronic medical records, Disease identification

### Content

In this course, we've discussed getting data from different parts of the healthcare system, how to put events on a patient timeline, how to construct features, the value of knowledge graphs, text, images, and signals. Now, we'll put all of this together to identify phenotypes. What is a phenotype? In the clinical context, a phenotype is a certain characteristic or condition of the patient that may be present or absent. The most common example is a disease. For example, we would say that a person either has or does not have type 2 diabetes. What is electronic phenotyping? Electronic phenotyping is a computational procedure for determining whether a patient does or does not have the condition of interest based on the electronic medical record. In addition, if they have the condition, when did it start and when did it end? In short, did it happen and when? Why is this useful? The process of electronic phenotyp ing is found throughout clinical research. Electronic phenotyping is useful for using observational data for research, as we've been talking about, recruiting patients into clinical trials, calculating quality metrics for healthcare systems that get publicly reported, finding similar patients, and sharing definitions to facilitate cross-sight research.

---

## 7. Probabilistic phenotyping.mp4

### Summary

To meet demanding deadlines in healthcare data science, researchers must pivot from manually defined rules to **automated phenotype construction**. This approach leverages **supervised machine learning** to identify specific medical conditions within large patient populations far more rapidly than human experts can. The primary challenge, however, lies in the need for **labeled training data**, which is traditionally labor-intensive and expensive to produce by hand. Consequently, the central goal of this methodology is to find **efficient ways to acquire labels** that are accurate enough to train a functional classification model.

**Keywords:** Probabilistic phenotyping, Machine learning, Phenotype construction, Supervised learning, Automated patient labeling

### Content

Now let's look at probabistic phenotyping. We'll start this section with a thought experiment. Suppose you're the chief data scientist at a healthcare startup. You need to identify patients who have one of 50 different conditions. The work needs to be done within one week. What could you do? One week is not long enough time to define and refine 50 different rule-based phenotypes using medical experts. Unless you're lucky and can build entirely upon prior work. The only way to complete Your task is to automate the phenotype construction process. This sounds like a job for machine learning. The core idea is to use supervised machine learning methods. Supervised machine learning starts with a training set with each patient explicitly labeled as having or not having the condition of interest and as of when in their timeline. The training data set is used to build a computational model that can classify whether a previously unseen patient has the condition or not. So now we need to have labeled examples, but labeling by hand is time inensive. Labeling is the very process that we're hoping to avoid. Can we somehow cheaply obtain labels that are good enough to train a classifier for our phenotype?

---

## 8. Rule-based electronic phenotyping.mp4

### Summary

This text describes a systematic method for identifying specific medical conditions within digital records using **rule-based electronic phenotyping**. By utilizing standardized repositories like the **Phenotype Knowledge Base**, researchers apply specific **inclusion and exclusion criteria** to accurately categorize patient data. For instance, a diagnosis of sickle cell disease requires a combination of **validated diagnostic codes** and a minimum frequency of medical encounters. Conversely, the logic filters out cases where contradictory evidence, such as a **higher prevalence of related but distinct traits**, suggests the primary condition is not actually present.

**Keywords:** Rule-based electronic phenotyping, Phenotype knowledge base, Inclusion and exclusion, Sickle cell disease, Patient identification criteria

### Content

We'll turn first to rule-based electronic phenotyping. We will use examples from the phenotype knowledge base or FKB. This is a publicly available repository of phenotype definitions. We will start with an example of a rule-based electronic phenotype that has a relatively simple definition. This phenotype is for identifying patients with cickle cell disease. The phenotype is listed on fkb.org. The phenotype has inclusion criteria and exclusion. criteria. The inclusion criteria are for features that must be present while the exclusion criteria are for features that must not be present. So for cickle cell disease, the inclusion criteria has two parts. A set of ICD9 codes at least one of which must appear and the requirement for one hospitalization or two office visits for this condition. The exclusion criteria has just one part which says that if the patient has more diagnoses for cickle cell trait than for cle cell disease, that do not determine the patient to have cickle cell disease.

---

## 9. Software for probabilistic phenotype definitions.mp4

### Summary

Aphrodite is an **open-source software** tool designed to streamline the complex process of **identifying and defining medical phenotypes** within large datasets. By utilizing the **standardized frameworks** of the Odyssey common data model and its associated vocabulary, the program ensures that health information is processed in a consistent and globally compatible manner. This resource automates the **labeling and evaluation** of patient data, providing a specialized solution for researchers seeking to translate raw observations into meaningful clinical definitions. The entire suite of code is **freely accessible on GitHub**, encouraging a collaborative and transparent approach to modern health data science.

**Keywords:** Aphrodite software, Open-source software, Phenotype definitions, Odyssey data model, GitHub code accessibility

### Content

One comprehensive solution which is available as open- source software is called Aphrodite for automated phenotype routine for observational definition identification training and evaluation. Yeah, it's a mouthful. It uses standardized open- source representations from the Odyssey common data model version 5, the vocabulary again version five, and it implements the labeling processes we just discussed. The code is freely available on GitHub for you to use.

---

## 10. Specifying an electronic phenotype.mp4

### Summary

Electronic phenotyping serves as a foundational process for identifying medical exposures or outcomes by establishing the **necessary and sufficient conditions** within digital patient data. Creating these definitions requires a precise balance of clinical criteria, such as **identifying start and end times** for conditions and distinguishing between a patient's current status and their **past medical history**. Because medical standards evolve and data varies across institutions, a major challenge lies in ensuring the **portability and accuracy** of these specifications compared to a clinician's manual review. Ultimately, the rigor of a phenotype definition must be tailored to the specific **research question** and the level of error a study can tolerate.

**Keywords:** Electronic phenotyping, Phenotype specification, Start and end, Portability of definitions, Evaluation and accuracy

### Content

So now that we know that electronic phenotyping is important, how do we specify an electronic phenotype? An electronic phenotype should contain the necessary and sufficient conditions of features that should be present or absent and the required values to determine if an exposure or outcome of interest happened to the patient. It should also contain the criteria for identifying the start and end times of those exposures. Locating the start time may be straightforward. forward, but it can be more difficult to determine when a condition ends. As an example, when does pneumonia end? The symptoms such as cough or difficulty breathing may last beyond the period of the acute infection. It might be hard to say exactly when the patient's pneumonia ended. When specifying a phenotype, it is very important to be clear about the intended meaning of that phenotype definition. Does it refer to a condition that the patient presently has, or does it refer to the patient's past medical history, a condition they had before. Both might be important, but they're not the same. And so, it matters how this phenotype is actually written down. Is it written in English or in some formal computer-based specification or some special language? And if you have a phenotype definition, how do you evaluate it? Does it actually find the patients that it claims to find? The reference standard is usually a comparison to a complete review of the patient charts by trained clinicians. However, this is time inensive and there may not be complete agreement. Remember to answer our questions we have to figure out exposures and outcomes. We have to decide on risk thresholds and we have to estimate the effects of treatments. All these tasks require electronic phenotyping which is declaring the necessary and sufficient conditions of the features that should be present or absent. and the required values to decide if an exposure outcome of interest happened to the patient. However, the definition of what constitutes a condition such as hypertension or diabetes is constantly changing, making electronic phenotyping a challenging but fun exercise. It's also important to realize that the accuracy of the phenotype definition depends on the research question you're trying to answer. If you know the magnitude of the effect you're looking for, you may be ble to figure out how much error in the phenotype definition can be tolerated by the analysis. The last issue to consider for evaluation is how well a phenotype definition based on data from one site will work at a second site. Often referred to as the portability of the electronic phenotype definition.

---

## 11. Two approaches to phenotyping.mp4

### Summary

Electronic phenotyping utilizes two distinct methodologies to identify specific patient traits or outcomes within digital health records. The traditional method relies on **expert-derived rules**, where specialists manually define strict inclusion and exclusion criteria through a repetitive process of consensus. In contrast, **probabilistic phenotyping** leverages **machine learning algorithms** to automatically analyze data and assign a likelihood score to an individual’s record. While the first approach is built on human clinical experience, the second focuses on **mathematical functions** to predict the presence of specific medical exposures or conditions. Together, these strategies provide a framework for translating complex electronic data into actionable clinical insights.

**Keywords:** Electronic phenotyping, Rule-based approach, Expert consensus, Probabilistic phenotyping, Machine learning

### Content

There are two categories of approaches to electronic phenotyping. The first approach which is the most common uses rules. The rules comprise of explicit inclusion and exclusion criteria that are constructed by experts who reach consensus on the criteria in an iterative fashion often looking at sample case records. The second approach is called probabilistic phenotyping. It uses machine learning instead of expert consensus to learn a function that assigns a probability to a pat. record for having the exposure or the outcome of interest.

---

## 12. Wrap Up Phenotype.mp4

### Summary

Modern medical researchers are shifting their perspective to view phenotypes as **complex data patterns** rather than simple, manual flowcharts or rule-based algorithms. By identifying recurring clusters of medications, lab results, and clinical notes, computers can more effectively define a patient's condition across vast electronic health records. This approach faces significant challenges, particularly regarding **portability and generalizability**, as a definition created in one hospital may not function accurately in another due to varying coding systems. Ultimately, the field is moving toward **probabilistic and automated execution**, seeking to create standardized computer programs that can reliably identify diseases across diverse healthcare environments.

**Keywords:** Phenotype data patterns, Electronic phenotyping, Executable definitions, Portability and generalizability, Probabilistic phenotyping methods

### Content

So let's back up a bit to a conceptual level. We want to highlight that it is very useful to think about phenotypes as patterns in the data. Most approaches tend to think of a phenotype as a set of rules or a flowchart often called an algorithm. Instead, consider the phenotype as a pattern of some variables in the data. For example, diabetes would be associated with a high prevalence of anti-diabetic drugs, maybe foot examination procedures and glucose measurements. Think about methods that could identif y those variables, those patterns, their importance and utility across the data sources we've discussed in this class, diagnosis and procedures, codes, lab orders, lab values, medication orders, even terms that appear in the clinical text. I will leave you with some open questions about electronic phenotyping. Ideally, a phenotype definition would be written in a way that allows for automatic execution of that definition by a machine. In essence, this means that they're computer programs. But the best representations are not yet that clear. Phenotype definitions are usually created at one location in a healthcare system. This raises the question of whether the same definition will perform well at another site. The definitions may use codes that are not even in use at the other sites. They may also require computing resources that are not available. There's no guarantee of generalizability and without testing, you would not know how accurate the definitions are when used elsewhere. So creating executable phenotype definitions and developing methods that provide some guarantees of portability are fun research areas to pursue. Also rule-based phenotypes are labor intensive to create. But we do not yet have enough comparisons of rulebased and probabilistic methods to know when is each approach best used. Proistic phenotyping is a great active area of research uh to work in.

---

